Jonathan Yen, director of therapeutic genome engineering at St. Jude Children's Research Hospital, optimizes and tests new gene therapies for sickle cell disease — in which an abnormal form of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback